• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性低钠血症患儿的管理挑战:V2受体拮抗剂的应用

Management Challenges in a Child with Chronic Hyponatremia: Use of V2 Receptor Antagonist.

作者信息

Krishnan Sowmya, Deshpande Swapna, Mallappa Ashwini, Divya Gunda, Lane Pascale, Vishwanath Anu, McNall-Knapp Rene Y

机构信息

Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

Department of Psychiatry, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

出版信息

Case Rep Pediatr. 2017;2017:3757423. doi: 10.1155/2017/3757423. Epub 2017 Jan 9.

DOI:10.1155/2017/3757423
PMID:28149654
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5253166/
Abstract

Chronic hyponatremia is very rare in children and is often seen in the setting of congestive heart failure or liver failure in adults. Here, we report an 8-year-old child with hypothalamic glioma who presented with severe hyponatremia. Initial management consisted of fluid restriction. This was very difficult for the child to follow and the child developed bizarre drinking habits requiring intervention from child psychiatry. So therapy was initiated with low dose V2 receptor antagonist under close inpatient monitoring. While initial response was reassuring, her sodium levels tended to drift down with longer duration of treatment requiring us to increase the dose frequently. Her response to therapy and her stable clinical situation off therapy suggest that she may have reset osmostat.

摘要

慢性低钠血症在儿童中非常罕见,在成人中常出现在充血性心力衰竭或肝功能衰竭的情况下。在此,我们报告一名8岁患有下丘脑胶质瘤的儿童,其出现了严重低钠血症。初始治疗包括限制液体摄入。这对该儿童来说很难遵循,并且该儿童养成了怪异的饮水习惯,需要儿童精神病学进行干预。因此,在密切的住院监测下开始使用低剂量V2受体拮抗剂进行治疗。虽然初始反应令人安心,但随着治疗时间延长,她的钠水平趋于下降,这要求我们频繁增加剂量。她对治疗的反应以及治疗停止后的稳定临床状况表明她可能已经重置了渗透压感受器。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbb6/5253166/dbecb6681a61/CRIPE2017-3757423.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbb6/5253166/dbecb6681a61/CRIPE2017-3757423.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbb6/5253166/dbecb6681a61/CRIPE2017-3757423.001.jpg

相似文献

1
Management Challenges in a Child with Chronic Hyponatremia: Use of V2 Receptor Antagonist.慢性低钠血症患儿的管理挑战:V2受体拮抗剂的应用
Case Rep Pediatr. 2017;2017:3757423. doi: 10.1155/2017/3757423. Epub 2017 Jan 9.
2
Reset Osmostat: A Challenging Case of Hyponatremia.重置渗透压调节中枢:一例具有挑战性的低钠血症病例
Case Rep Med. 2018 Nov 4;2018:5670671. doi: 10.1155/2018/5670671. eCollection 2018.
3
Reset Osmostat: The Result of Chronic Desmopressin Abuse?重置渗透压调节:慢性去氨加压素滥用的结果?
Am J Kidney Dis. 2017 Jun;69(6):853-857. doi: 10.1053/j.ajkd.2016.12.009. Epub 2017 Feb 20.
4
The role of V2 vasopressin antagonists in hyponatremia.V2加压素拮抗剂在低钠血症中的作用。
Cardiovasc Res. 2001 Aug 15;51(3):403-8. doi: 10.1016/s0008-6363(01)00288-7.
5
A case of persistent hyponatraemia due to reset osmostat.一例因渗透压调定点重置导致的持续性低钠血症。
Med J Malaysia. 2006 Dec;61(5):638-40.
6
Management of hyponatremia.低钠血症的管理。
Am Fam Physician. 2004 May 15;69(10):2387-94.
7
Lixivaptan, a non-peptide vasopressin V2 receptor antagonist for the potential oral treatment of hyponatremia.利克昔泮,一种非肽类血管加压素V2受体拮抗剂,用于低钠血症的潜在口服治疗。
IDrugs. 2010 Nov;13(11):782-92.
8
Chronic hyponatremia due to reset osmostat in a patient with colon cancer.一名结肠癌患者因渗透压调定点重置导致慢性低钠血症。
Am J Nephrol. 1996;16(4):349-51. doi: 10.1159/000169022.
9
Aquaretic effect of lixivaptan, an oral, non-peptide, selective V2 receptor vasopressin antagonist, in New York Heart Association functional class II and III chronic heart failure patients.口服非肽类选择性V2受体血管加压素拮抗剂利希普坦对纽约心脏协会心功能II级和III级慢性心力衰竭患者的利水作用。
J Am Coll Cardiol. 2006 Apr 18;47(8):1615-21. doi: 10.1016/j.jacc.2005.11.071. Epub 2006 Mar 29.
10
Reset osmostat and salt and water retention in the course of severe hyponatremia.在严重低钠血症病程中重置渗透压感受器以及盐和水潴留。
Medicine (Baltimore). 2003 May;82(3):170-6. doi: 10.1097/01.md.0000076007.64510.15.

引用本文的文献

1
Corrigendum to "Management Challenges in a Child with Chronic Hyponatremia: Use of V2 Receptor Antagonist".《慢性低钠血症患儿的管理挑战:V2受体拮抗剂的应用》勘误
Case Rep Pediatr. 2017;2017:8132129. doi: 10.1155/2017/8132129. Epub 2017 Jul 2.

本文引用的文献

1
Ten common pitfalls in the evaluation of patients with hyponatremia.低钠血症患者评估中的十个常见误区。
Eur J Intern Med. 2016 Apr;29:22-5. doi: 10.1016/j.ejim.2015.11.022. Epub 2015 Dec 17.
2
Disorders of plasma sodium--causes, consequences, and correction.血浆钠紊乱——病因、后果及纠正
N Engl J Med. 2015 Jan 1;372(1):55-65. doi: 10.1056/NEJMra1404489.
3
Disorders of sodium and water balance.钠和水平衡紊乱
Emerg Med Clin North Am. 2014 May;32(2):379-401. doi: 10.1016/j.emc.2014.01.001. Epub 2014 Mar 4.
4
Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations.低钠血症的诊断、评估和治疗:专家小组建议。
Am J Med. 2013 Oct;126(10 Suppl 1):S1-42. doi: 10.1016/j.amjmed.2013.07.006.
5
Syndrome of inappropriate ADH secretion and severe osteoporosis.抗利尿激素分泌不当综合征与严重骨质疏松症。
J Clin Endocrinol Metab. 2012 Dec;97(12):4306-10. doi: 10.1210/jc.2012-2031. Epub 2012 Oct 17.
6
Hyponatremia: diagnosis, complications, and management including V2 receptor antagonists.低钠血症:诊断、并发症和治疗,包括 V2 受体拮抗剂。
Curr Opin Nephrol Hypertens. 2011 Mar;20(2):161-8. doi: 10.1097/MNH.0b013e3283436f14.
7
Lesions of the hypothalamus: MR imaging diagnostic features.下丘脑病变:磁共振成像诊断特征
Radiographics. 2007 Jul-Aug;27(4):1087-108. doi: 10.1148/rg.274065123.
8
Psychogenic polydipsia review: etiology, differential, and treatment.精神性烦渴综述:病因、鉴别诊断及治疗
Curr Psychiatry Rep. 2007 Jun;9(3):236-41. doi: 10.1007/s11920-007-0025-7.
9
Reset osmostat and salt and water retention in the course of severe hyponatremia.在严重低钠血症病程中重置渗透压感受器以及盐和水潴留。
Medicine (Baltimore). 2003 May;82(3):170-6. doi: 10.1097/01.md.0000076007.64510.15.
10
Hyponatremia secondary to reset osmostat in a child with a central nervous system midline defect and a chromosomal abnormality.
J Pediatr Endocrinol Metab. 2000 Nov-Dec;13(9):1637-41. doi: 10.1515/jpem.2000.13.9.1637.